MS trades against a final fair-value range of $89.88-$161.78, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $89.9, high $162, with mid-point at $128.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$128
Margin of safety
-50.8%
Confidence
88/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$193.09Price
Low $89.88
Mid $128.06
High $161.78
MS trades against a final fair-value range of $89.88-$161.78, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Scale and brand prestige in
Scale and brand prestige in Wealth Management ($5T+ client assets).
Top-three global ranking in Equities
Top-three global ranking in Equities and Investment Banking.
Cycle upside
Expanding global money supply, robust IPO/M&A activity, and rising equity markets driving AUM growth.
Reverse DCF for MS (MS) backs out the revenue or earnings growth rate the current share price implies, holding terminal value, margin, and discount-rate assumptions constant.
We compare the implied rate to our own forecast deceleration curve and to the historical five-year actual. When the implied rate exceeds the realistic ceiling, the price is pricing in optimism the business has not yet demonstrated.
Reverse DCF uses cost of equity (Ke), not WACC, to stay consistent with the EPS-based forward valuation models. Ke is derived from CAPM with adjusted beta; the strict and moderate variants are documented in the assumption ledger.
When the implied growth rate is below our forecast, the market is underpricing the business; when it is above, the market is overpricing. The reverse-DCF read is one of four lenses that feed the composite fair-value range and the rating band.
FAQ
MS — frequently asked questions
Based on our latest analysis, MS looks meaningfully overvalued. The current price is $193 versus a composite fair-value midpoint of $128 (range $89.9–$162), which implies roughly 33.7% downside to the midpoint.
Our composite fair-value range for MS is $89.9–$162, with a midpoint of $128. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for MS's archetype.
Our current rating for MS is Sell with a confidence score of 88/100. MS is rated Sell at $193.09 versus the reconciled fair value midpoint of $128.06, implying -33.68% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for MS are: Severe Equity Market Drawdown; Wealth Management Margin Compression; Regulatory Capital Penalties. The single biggest risk is Severe Equity Market Drawdown: A prolonged 20%+ market correction drives severe AUM attrition, compressing fee yields and crushing capital markets activity simultaneously.
Our current rating for MS is Sell, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($89.9–$162) versus the current price of $193.
MS is classified as a financial stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for MS.